Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88K Sell
27
-2
-7% -$242 ﹤0.01% 859
2026
Q1
$4.74K Hold
29
﹤0.01% 764
2025
Q4
$5.05K Hold
29
﹤0.01% 758
2025
Q3
$4.18K Buy
+29
New +$3.55K ﹤0.01% 804

Other funds holding INSM

Clearstead Trust's INSM Position: Q2 2026 in Review

Clearstead Trust reduced its Insmed (INSM) stake by 6.9% in Q2 2026, selling an estimated $242 and leaving 27 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

Clearstead Trust first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.05K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Clearstead Trust held 27 shares of Insmed worth $2.88K as of Q2 2026.
  • Clearstead Trust sold 2 Insmed shares in Q2 2026, an estimated $242.
  • Insmed made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #859 holding.
  • Clearstead Trust first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Clearstead Trust's Insmed position peaked at $5.05K in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.